These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3518475)

  • 1. Participation of neutrophils and delayed hypersensitivity in the clearance of experimental cutaneous candidiasis in mice.
    Wilson BD; Sohnle PG
    Am J Pathol; 1986 May; 123(2):241-9. PubMed ID: 3518475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs.
    Sohnle PG; Frank MM; Kirkpatrick CH
    J Immunol; 1976 Aug; 117(2):523-30. PubMed ID: 781132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil accumulation and cutaneous responses in experimental cutaneous candidiasis of genetically complement-deficient mice.
    Wilson BD; Sohnle PG
    Clin Immunol Immunopathol; 1988 Feb; 46(2):284-93. PubMed ID: 2827924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental cutaneous candidiasis in rodents.
    Ray TL; Wuepper KD
    J Invest Dermatol; 1976 Jan; 66(1):29-33. PubMed ID: 1107433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of dermal invasion in experimental cutaneous candidiasis of leucopenic mice.
    Hahn BL; Sohnle PG
    J Invest Dermatol; 1988 Sep; 91(3):233-7. PubMed ID: 3045209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal proliferation and the neutrophilic infiltrates of experimental cutaneous candidiasis in mice.
    Sohnle PG; Hahn BL
    Arch Dermatol Res; 1989; 281(4):279-83. PubMed ID: 2774659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fate of individual organisms during clearance of experimental cutaneous Candida albicans infections in mice.
    Sohnle PG; Hahn BL
    Acta Derm Venereol; 1992 Aug; 72(4):241-4. PubMed ID: 1357874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hair growth cycles on experimental cutaneous candidiasis in mice.
    Sohnle PG; Collins-Lech C; Hahn B
    J Invest Dermatol; 1986 May; 86(5):556-9. PubMed ID: 3745965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological and histopathological characterization of cutaneous candidiasis.
    Campois TG; Zucoloto AZ; de Almeida Araujo EJ; Svidizinski TIE; Almeida RS; da Silva Quirino GF; Harano RM; Conchon-Costa I; Felipe I
    J Med Microbiol; 2015 Aug; 64(8):810-817. PubMed ID: 26271575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal proliferation in the defense against experimental cutaneous candidiasis.
    Sohnle PG; Kirkpatrick CH
    J Invest Dermatol; 1978 Mar; 70(3):130-3. PubMed ID: 632616
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of immunosuppression on epidermal defenses in a murine model of cutaneous candidiasis.
    Sohnle PG; Hahn BL
    J Lab Clin Med; 1989 Jun; 113(6):700-7. PubMed ID: 2732618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans.
    Kagami S; Rizzo HL; Kurtz SE; Miller LS; Blauvelt A
    J Immunol; 2010 Nov; 185(9):5453-62. PubMed ID: 20921529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective neutrophil chemotaxis and cellular immunity in a child with recurrent infections.
    Clark RA; Root RK; Kimball HR; Kirkpatrick CH
    Ann Intern Med; 1973 Apr; 78(4):515-9. PubMed ID: 4571567
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of pseudohyphal growth as a neutrophil-mediated host defense mechanism against experimental deep Candida albicans infections in mice.
    Sohnle PG; Hahn BL
    J Lab Clin Med; 1993 Feb; 121(2):235-43. PubMed ID: 8433039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer factor in the treatment of a case of chronic mucocutaneous candidiasis.
    Schulking ML; Adler WH; Altemeier WA; Ayoub EM
    Cell Immunol; 1972 Apr; 3(4):606-15. PubMed ID: 4554089
    [No Abstract]   [Full Text] [Related]  

  • 16. [Candida albicans--interactions with the mucosa and the immune system].
    Schaller M
    J Dtsch Dermatol Ges; 2006 Apr; 4(4):328-36; quiz 337-8. PubMed ID: 16638063
    [No Abstract]   [Full Text] [Related]  

  • 17. Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy.
    Paterson PY; Semo R; Blumenschein G; Swelstad J
    Clin Exp Immunol; 1971 Nov; 9(5):595-602. PubMed ID: 4947556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Delayed hypersensitivity to Candida albicans].
    Frolova EV; Prokrovskaia OL; Karaev ZO
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Aug; (8):103-7. PubMed ID: 2238997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of an experimental mouse Candida infection by human dialyzable leukocyte extract.
    Sen P; Smith JK; Buse M; Hsieh HC; Lavenhar MA; Lintz D; Louria DB
    Sabouraudia; 1982 Jun; 20(2):85-93. PubMed ID: 7051369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nature of the restructuring of the T- and B-immunity systems in patients with cutaneous and visceral candidiasis].
    Karaev ZO; Krylov VA; Nikiforov IuF; Pokrovskaia OL
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Oct; (10):52-5. PubMed ID: 6362292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.